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Abstract
Background: Studying the impact of genetic testing inter-
ventions on lifestyle behaviour change has been a priority 
area of research in recent years. Substantial heterogeneity 
exists in the results and conclusions of this literature, which 
has yet to be explained using validated behaviour change 
theory and an assessment of the quality of genetic interven-
tions. The theory of planned behaviour (TPB) helps to explain 
key contributors to behaviour change. It has been hypoth-
esized that personalization could be added to this theory to 
help predict changes in health behaviours. Purpose: This 
systematic review provides a detailed, comprehensive iden-
tification, assessment, and summary of primary research 
articles pertaining to lifestyle behaviour change (nutrition, 
physical activity, sleep, and smoking) resulting from genetic 
testing interventions. The present review further aims to 
provide in-depth analyses of studies conducted to date 
within the context of the TPB and the quality of genetic in-
terventions provided to participants while aiming to deter-
mine whether or not genetic testing facilitates changes in 
lifestyle habits. This review is timely in light of a recently pub-
lished “call-to-action” paper, highlighting the need to incor-
porate the TPB into personalized healthcare behaviour 
change research. Methods: Three bibliographic databases, 
one key website, and article reference lists were searched for 
relevant primary research articles. The PRISMA Flow Diagram 
and PRISMA Checklist were used to guide the search strategy 
and manuscript preparation. Out of 32,783 titles retrieved, 
26 studies met the inclusion criteria. Three quality assess-
ments were conducted and included: (1) risk of bias, (2) qual-
ity of genetic interventions, and (3) consideration of theo-
retical underpinnings – primarily the TPB. Results: Risk of 
bias in studies was overall rated to be “fair.” Consideration of 
the TPB was “poor,” with no study making reference to this 
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validated theory. While some studies (n = 11; 42%) made ref-
erence to other behaviour change theories, these theories 
were generally mentioned briefly, and were not thoroughly 
incorporated into the study design or analyses. The genetic 
interventions provided to participants were overall of “poor” 
quality. However, a separate analysis of studies using con-
trolled intervention research methods demonstrated the 
use of higher-quality genetic interventions (overall rated to 
be “fair”). The provision of actionable recommendations in-
formed by genetic testing was more likely to facilitate be-
haviour change than the provision of genetic information 
without actionable lifestyle recommendations. Several stud-
ies of good quality demonstrated changes in lifestyle habits 
arising from the provision of genetic interventions. The most 
promising lifestyle changes were changes in nutrition. Con-
clusions: It is possible to facilitate behaviour change using 
genetic testing as the catalyst. Future research should en-
sure that high-quality genetic interventions are provided to 
participants, and should consider validated theories such as 
the TPB in their study design and analyses. Further recom-
mendations for future research are provided.
© 2018 S. Karger AG, Basel
Introduction
Since decoding the entire human genome in 2003 [1], 
there have been considerable advances in genetic research 
and the clinical utility of genetic testing. The terms nutri­
genomics or nutritional genomics describe the study of 
how genes interact with the foods, beverages, and supple-
ments consumed to influence health outcomes [2]. Cur-
rently, there are no generally accepted or standardized 
terms describing the study of how genes interact with 
physical activity, sleep, or smoking to influence subse-
quent health outcomes. These gene-lifestyle interactions 
can be referred to using the broad term lifestyle genomics. 
Despite the lack of a standardized terminology, research 
pertaining to nutrigenomics and other emerging genom-
ic sciences continues to advance. Specifically, behaviour 
change guided by genetic testing results or other person-
alized healthcare information is emerging as a priority 
area of research, with several reviews on this topic pub-
lished in recent years [3–6].
Genetic testing is increasingly used in clinical practice 
to provide personalized information and recommenda-
tions about health risks and lifestyle habits at a relatively 
low cost [7]. However, studies assessing whether or not 
genetic testing promotes changes in lifestyle habits have 
conflicting findings [8–11]. Given that chronic diseases 
can often be managed through lifestyle interventions 
alone, or a combination of lifestyle interventions and 
medication [12–14], genetic tests providing personalized 
lifestyle recommendations hold considerable promise.
Behaviour change is a multifactorial, complex area of 
research and clinical practice. The theory of planned be-
haviour (TPB) is arguably the most widely accepted be-
haviour change theory in academia [15]. This theory pos-
its that attitudes, subjective norms, and perceived behav-
ioural control are key constructs that can be used to 
predict behaviours. Actual behavioural control, which 
typically refers to factors such as income, educational lev-
el, and other social determinants of health for the pur-
poses of healthcare research, further contributes to one’s 
likelihood of performing a behaviour [15, 16]. It is impor-
tant for genetic testing behaviour change research to con-
sider validated theories in order to control for a number 
of confounding factors that could significantly influence 
the results of a study.
Despite the complexity of behaviour change, genetic 
testing behaviour change studies do not often use any the-
oretical underpinnings to inform their study design, or 
for the analysis and interpretation of their data. This is 
concerning, as it implies that these studies did not report 
whether they considered the many confounding factors 
impacting behaviour change, including but not limited to 
attitudes, subjective norms, and perceived and actual be-
havioural control [17]. Consideration of such factors 
could help explain why some studies conclude that ge-
netic testing facilitates health behaviour change, while 
others conclude that it does not. For example, a study may 
find that genetic testing has a positive influence on atti-
tudes and subjective norms, but it is only when behav-
ioural control is high (for example, with a higher income 
or education level) that genetic testing facilitates health 
behaviour change. The importance of such consider-
ations has been highlighted in a recent call to action for 
personalized healthcare behaviour change research, 
which recommended the completion of a systematic re-
view with perspective from the TPB as an important next 
step in advancing knowledge in personalized healthcare 
behaviour change literature [18].
Systematic reviews and meta-analyses are typically 
considered the highest quality of scientific evidence and, 
notably, often guide clinical practice [19]. When it comes 
to systematic reviews assessing behaviour change as a re-
sult of genetic testing interventions, a simple risk-of-bias 
assessment is not sufficient to develop the most meaning-
ful conclusions; yet it is often the only quality assessment 
conducted in this type of work [3, 5, 6]. It is further im-
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portant to consider the delivery of a health/genetic inter-
vention (such as considering the provision of disease risk 
estimates vs. actionable behaviour change recommenda-
tions) and to consider behaviour change theories [18]. 
Therefore, the development of more comprehensive 
methods for reviewing and compiling the primary re-
search articles conducted to date related to genetic testing 
behaviour change is needed.
The present review provides an in-depth analysis and 
summary of the current body of knowledge, thus present-
ing the most robust and comprehensive review of genetic 
testing behaviour change research conducted to date. 
Overall, the purpose of this comprehensive systematic re-
view is to use these novel perspectives to answer the fol-
lowing research questions: Are we considering validated 
behaviour change theory (particularly the TPB) in genet-
ic testing behaviour change research? Are we using high-
quality genetic interventions in genetic testing behaviour 
change research? What is the impact of genetic testing on 
behaviour change pertaining to four lifestyle factors: nu-
trition, physical activity, smoking, and/or sleep? These 
four lifestyle factors were chosen as they have all been 
shown to have a significant impact on chronic disease 
management [20–24]. Behaviour change is challenging, 
and it is important to find strategies that effectively fa-
cilitate beneficial lifestyle changes related to nutrition, 
physical activity, smoking, and/or sleep. Genetic tests 
may provide information on disease risk, which can be 
mitigated through specific alterations in lifestyle habits 
such as improving nutrition, optimizing physical activity 
habits, quitting smoking or smoking less, and engaging in 
healthful sleep-related behaviours.
Methods
Search Strategy
The systematic review protocol that was used to guide this re-
view is detailed elsewhere [25]. In brief, the search strategy was 
guided by the PRISMA Flow Diagram [26]. From February to 
April 2017, the following databases were searched for relevant ar-
ticles: PubMed, Scopus, and Nursing & Allied Health. Publications 
posted on the Food4Me website [27], as well as the reference lists 
of 4 recent review articles published on topics similar to those of 
the present review [3–6], were also screened for articles relevant to 
the research questions. After the number of records had been con-
densed through title and abstract screening, the full-text articles 
were reviewed to assess each one for eligibility according to pre-
determined inclusion and exclusion criteria. The complete search 
terms and search strategy were developed and approved by all au-
thors, and they are detailed in Figure 1 and Figure 2, respectively.
Selection Criteria
To capture a comprehensive summary of the research conduct-
ed to date, the present review was not limited to a single, specific 
study design. We included primary research articles published in 
English in peer-reviewed journals from all years which assessed the 
impact of genetic testing on one or more of the four lifestyle habits 
of interest (nutrition, physical activity, smoking, and/or sleep). 
Both qualitative and quantitative studies were included. Studies 
were excluded if there was not at least one group of participants 
who underwent genetic testing and/or if the study did not provide 
follow-up data related to one or more of the lifestyle habits of in-
terest after the participants had received the results of a genetic test. 
One author (J.H.) completed data extraction using piloted forms 
[28], which were tested on 4 studies, reviewed by another author 
(J.G.), and modified during the piloting process by two authors 
(J.H. and J.G.).
Analysis
The National Institutes of Health (NIH) Study Quality Assess-
ment Tools were used to conduct a risk-of-bias assessment in 
quantitative research [29]. The Critical Appraisal Skills Pro-
gramme Qualitative Research Checklist [30] was used to assess risk 
of bias in qualitative research. The quality of the genetic interven-
tion was also assessed. To our knowledge, there currently is no tool 
available for assessing the quality of a genetic intervention. As 
such, we developed the first assessment tool for evaluating the 
quality of a genetic intervention provided to subjects (online sup-
pl. Table 1; see www.karger.com/doi/10.1159/000488086 for all 
online suppl. material). The quality rating and general outline for 
this new tool was based on the format of the NIH Study Quality 
Assessment Tools [29]. The questions included were developed 
from a review of previously identified critiques and concerns re-
lated to genetic testing and health risk messages [11, 31–38].
Consideration of the main components of the TPB (attitudes 
towards a behaviour, subjective norms, behavioural control, and 
intention) [17], as well as consideration of theory more generally, 
was assessed using deductive content analysis of the manuscripts 
nutrigenetic* OR nutrigenomic* OR  DNA OR “nutritional genomic*” OR gene OR genes OR 
genetic* OR genom* OR “personalized nutrition” OR “personalised nutrition” 
AND
behavior* OR behaviour* OR habit* OR smoking OR smoke* OR diet OR nutrition OR “physical 
activity” OR exercise OR sleep 
AND
change OR changes OR effect OR effects OR impact OR impacts OR modif* 
AND
information OR recommendation* OR advice OR intervention OR program* OR counsel* Fig. 1. Search terms.
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[39]. The deductive content analyses of consideration of the TPB 
and its key components in each study was then translated into a 
rating, based on the rating system generated in the NIH Study 
Quality Assessment Tools, whereby “good” indicates a robust con-
sideration of the main components of the TPB, “fair” indicates 
intermediate consideration of the main TPB components, and 
“poor” represents little to no consideration of the main TPB com-
ponents. An overall quality score was assigned to each article based 
on a point system, where “good” ratings were awarded 3 points, 
“fair” ratings were awarded 2 points, and “poor” ratings were 
awarded 1 point. The maximum possible overall quality rating was 
9/9, upon consideration of all three assessments.
Results
The comprehensive electronic literature search re-
turned a total of 32,783 results, with 26 studies meeting 
the predetermined inclusion criteria. In these 26 studies, 
the following outcomes were assessed: nutrition (n = 18), 
physical activity (n = 16), and smoking (n = 12) (Fig. 1), 
with 14 articles assessing more than one lifestyle habit of 
interest to this review. The vast majority of the literature 
has been published over the past decade, with a large spike 
in publications recently in 2015 (online suppl. Fig.  1). 
Consistent with recommendations for systematic reviews 
[25], our review was analytic and descriptive in nature 
and included: (a) a tabulation of the study characteristics 
and findings (Table 1); (b) a thorough and robust quality 
assessment (Table 2); and (c) a narrative synthesis. Re-
search conducted thus far has focused on a variety of 
genes, as outlined in Table 3. It is concerning to note that 
12 studies (46%) did not report whether or not the au-
thors had a conflict of interest (COI). The vast majority 
of the literature has focused on genetic testing for deter-
mining the risk of developing certain diseases or condi-
tions (88%; n = 23), while only a small number of studies 
have focused on nutrient metabolism (12%; n = 3), which 
indirectly affects the risk of developing diseases or con-
ditions [40–42]. The three separate quality assessments 
completed on each study are summarized in Table 2. Risk 
of bias was overall rated as “fair.”
Are We Using High­Quality Genetic Interventions?
Although some risk of bias is apparent, the ratings for 
the quality of the genetic interventions were more con-
Records identified through
database searches
(n = 32,557)
Records screened
(n = 32,783)
Records excluded as they did
not meet predetermined
inclusion/exclusion criteria
(n = 32,713)
Full-text articles excluded
with reasons (n = 44):
Ineligible outcome: n = 27
Not primary research: n = 10
Ineligible intervention: n = 4
Ongoing study: n = 2
Poster presentation: n = 1
Full-text articles assessed for eligibility
(n = 70)
Studies included in qualitative synthesis* (n = 26):
Nutrition (n = 18)
Physical activity (n = 16)
Sleep (n = 0)
Smoking (n = 12)
Records identified through
other sources
(n = 226)
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Fig. 2. Search strategy guided by the PRISMA Flow Diagram. * Several articles assessed behaviour change related 
to > 1 lifestyle factor of interest; therefore, the total number of records included in the systematic review does not 
match the total number of articles by lifestyle category.
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Table 1. Summary of study characteristics and behaviour change findings
First author 
[Ref.], date
Participants 
(n baseline; 
n follow-up)
Interven-
tion 
group(s)
Comparison 
group(s)
Target diseases/
conditions 
(genes tested)
Follow-up Lifestyle habits 
assessed
Outcomes (p values); 
conclusions
Ranking 
of study 
design1
COI
Roke [43], 
2017 
Young female 
adults 
(n = 57; 
n = 56)
Genetic 
testing
No genetic 
testing
Health effects related 
to omega-3 intake 
(FADS1)
3 months Nutrition 
(omega-3: 
EPA and DHA)
NS change in omega-3 
intake in the genetic 
testing group compared 
to the control group (no 
genetic testing)
1 No
Marsaux [10], 
2016
Adults 
(n = 265; 
n = 130)
High-risk 
genetic 
result 
Non-risk 
genetic result
Overweight/
obesity (FTO)
6 months Physical activity NS change in subjective 
or objective physical 
activity with provision of 
FTO genotype risk info
3 Yes
Meisel [44], 
2015
Young adults 
(n = 1,016; 
n = 279)
Genetic 
testing
No genetic 
testing
Obesity (FTO) 1 month Nutrition (adher-
ence to a variety 
of eating behav-
iours) and physi-
cal activity
NS changes in nutrition 
and physical activity 
(pooled) between groups
1 No
Boeldt [45], 
2015
Adults working 
at health and 
technology 
companies 
(NR; n = 2,037)
Genetic 
testing
None 23 conditions includ-
ing heart attack, 
Alzheimer disease, 
type 2 diabetes, 
obesity, colon cancer, 
and cervical cancer 
(NR)
5.6±2.4 
months
Nutrition 
(dietary fat) and 
physical activity
NS (significance level 
NR) change in nutrition 
and physical activity 
following genetic testing2
4 No
Hieteranta-
Luoma [9], 
2015
Adults 
(n = 122; 
n = 113 at 
12 months)
Genetic 
testing
and
High-risk 
genetic 
result
No genetic 
testing
and
Non-risk 
genetic result
Cardiovascular 
disease (apoE)
2 weeks
6 months
12 months
Nutrition (fat 
quality, and 
consumption of 
vegetables, ber-
ries, fruits, and 
fatty and sugary 
foods) and physi-
cal activity
Improved dietary fat 
quality in the high-risk 
genetic result group vs. 
the control group at 2 
weeks (p < 0.05) and 6 
months of follow-up (p < 
0.05); decreased intake of 
high-fat, high-sugar 
foods in the non-risk 
genetic result group vs. 
the control group at 12 
months (p < 0.05)
1 No
Voils [46], 
2015
Veterans 
(n = 601; 
n = 506 at 
3 months, 
n = 472 at 
6 months)
Genetic 
testing
No genetic 
testing
Type 2 diabetes 
(TCF7L2, PPARγ, 
and KCNJ11)
3 months
6 months
Nutrition (calo-
ries, carbohy-
drates, protein, 
fat, saturated fat, 
MUFA, and 
PUFA) and 
physical activity
Reduced calories and fat 
(MUFA and PUFA) in 
the genetic testing group 
vs. the no-genetic-testing 
group (p < 0.05) at 3 
months; NS changes in 
nutrition between the 
groups at 6 months; NS 
changes in physical 
activity at either time 
point
1 Yes
Marsaux [47], 
2015
Adults 
(n = 1,607; 
n = 1,233 with 
subjective data 
at 6 months, 
n = 730 with ob-
jective data at 
6 months)
Genetic 
testing
No genetic 
testing
Overweight/
obesity (FTO)
3 months
6 months
Physical activity NS changes in physical 
activity with the addition 
of genetic information
1 Yes
Nielsen [11], 
2014
Adults 
(n = 138; 
n = 130 at 
3 months, 
n = 123 at 
12 months)
High-risk 
genetic 
result
and
Non-risk 
genetic 
result
No genetic 
testing
Caffeine metabolism 
(CYP1A2), vitamin C 
utilization (GSTT1 
and GSTM1), sweet 
taste perception 
(TAS1R2), and 
sodium sensitivity 
(ACE)
3 months
12 months
Nutrition (caf-
feine, vitamin C, 
added sugar, and 
sodium)
The high-risk genetic 
result group (for the 
ACE gene) had reduced 
sodium intake to a 
greater extent than the 
control group by the 
12-month follow-up (p = 
0.008); NS changes in 
caffeine, vitamin C, and 
added sugar intake at 
each follow-up time 
point; NS changes in 
sodium intake at the 
3-month follow-up
1 Yes
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First author 
[Ref.], date
Participants 
(n baseline; 
n follow-up)
Interven-
tion 
group(s)
Comparison 
group(s)
Target diseases/
conditions 
(genes tested)
Follow-up Lifestyle habits 
assessed
Outcomes (p values); 
conclusions
Ranking 
of study 
design1
COI
Egglestone 
[8], 2013
Adults who had 
purchased a 
DTC genetic 
test or were 
considering 
purchasing a 
test or who were 
awaiting their 
results 
(n = 275)
Genetic 
testing
No genetic 
testing
NR (NR) Varied Nutrition (health-
ier diet, vitamins/
supplements, 
caffeine, fibre, 
salt, fat, and 
fruits/vegetables), 
physical activity, 
and smoking
Greater health behaviour 
scores in the genetic 
testing group vs. the 
control group (p = 0.02 
for pooled nutrition, 
physical activity, and 
smoking); the most 
common changes were 
“healthier diet,” “more 
exercise,” and “taking 
vitamins or supple-
ments”; more often 
reported “sufficient fruit 
and vegetable intake” in 
the genetic testing group 
(p = 0.03); NS changes in 
smoking individually
2 NR
Bloss [48], 
2013
Adults working 
at health and 
technology 
companies 
(n = 3,639; 
n = 2,037 at 
3 months, n = 
1,325 at 14±
1.3 months)
Genetic 
testing
None Deep vein thrombo-
sis, melanoma, 
sarcoidosis, haemo-
chromatosis, lactose 
intolerance, breast 
cancer, prostate 
cancer + 20 other 
conditions not listed 
(variable)
3 months 
14±1.3 
months
Nutrition (dietary 
fat) and physical 
activity
NS changes in nutrition 
or physical activity at 
3 months (significance 
level NR) or 14±1.3 
months
4 No
Kaufman [49], 
2012
Adult 
customers of 
DTC genetic 
testing 
companies 
(n = 3,167; 
n = 1,048)
Genetic 
testing
and
High-risk 
genetic 
result
Non-risk 
genetic result
Variable 
(variable)
2–8 months Nutrition (change 
diet) and physical 
activity
The participants who 
considered themselves at 
high risk of colon cancer 
were significantly more 
likely to change their diet 
(p = 0.02) and start 
exercising more (p = 
0.01) than those who 
considered themselves at 
low risk of colon cancer; 
10% of all participants 
reported they changed a 
supplement, 33% report-
ed being more careful 
about their diet, and 14% 
reported exercising more
2 NR
Hollands [50], 
2012
Adults with 
1st-degree 
relatives with 
Crohn disease 
(n = 497; 
n = 426)
Genetic 
testing
and
High-risk 
genetic 
result
No genetic 
testing
and
Non-risk 
genetic result
Crohn disease 
(NOD2)
6 months Smoking NS changes in smoking 
cessation between the 
genetic testing and the 
no-genetic-testing group; 
NS changes in smoking 
cessation between the 
high-risk and the non-
risk genetic result group 
(significance level NR)
1 No
Bloss [36], 
2011
Adults working 
at health and 
technology 
companies 
(n = 3,639; 
n = 2,037)
Genetic 
testing
None 23 conditions 
including breast 
and prostate 
cancer (NR)
5.6±2.4 
months
Nutrition (dietary 
fat) and physical 
activity
NS changes in nutrition 
and/or physical activity 
following genetic testing
4 NR
Vernarelli 
[51], 2010
Adults with at 
least one parent 
who developed 
Alzheimer 
disease 
(n = 279; 
n = 272)
High-risk 
genetic 
result
Non-risk 
genetic result
Alzheimer 
disease (apoE)
6 weeks Nutrition (dietary 
supplement use) 
and physical 
activity
The high-risk genetic 
result group was more 
likely to take supple-
ments than the non-risk 
genetic result group 
(p = 0.0001)
3 No
Table 1 (continued)
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First author 
[Ref.], date
Participants 
(n baseline; 
n follow-up)
Interven-
tion 
group(s)
Comparison 
group(s)
Target diseases/
conditions 
(genes tested)
Follow-up Lifestyle habits 
assessed
Outcomes (p values); 
conclusions
Ranking 
of study 
design1
COI
Hishida [52], 
2010
Adult smokers 
(n = 562; 
n = 533)
Genetic 
testing
No genetic 
testing
Lung and 
oesophageal cancer 
(L-myc)
12 months Smoking NS changes in smoking 
cessation between the 
genetic testing and the 
no-genetic-testing group
1 No
Quach [53],  
2009
Adults with a 
personal and/or 
family history of 
breast and/or 
ovarian cancer 
(n = 120; NR)
Genetic 
testing
None Breast and ovarian 
cancer (BRCA1/2)
6 months Nutrition (healthy 
diet and vitamin 
use) and physical 
activity
NS changes in nutrition, 
vitamin use, or physical 
activity after genetic 
testing (significance level 
NR)
4 NR
O’Neill [54], 
2008
Adult females 
(NR; n = 115 at 
1 month and 
6 months)
High-risk 
genetic 
result
Uninforma-
tive genetic 
result
and
Non-risk 
genetic result
Breast cancer 
(BRCA1/2)
1 month
6 months
Nutrition (satu-
rated fat, fruit/
vegetables) and 
physical activity
NS differences between 
groups in nutrition or 
physical activity at 
baseline and 1 month or 
6 months following 
genetic testing
3 NR
Chao [55], 
2008
Adult with 
parent who 
developed 
Alzheimer 
disease 
(n =162; 
n = 147)
Genetic 
testing
and
High-risk 
genetic 
result
No genetic 
testing
and
Non-risk 
genetic result
Alzheimer disease 
(apoE)
12 months Nutrition (chang-
es in diet, changes 
in vitamin/
supplement use) 
and physical 
activity
The high-risk genetic 
result group was more 
likely to report a nutri-
tion or physical activity 
change than the non-risk 
genetic result group (p = 
0.003) and the no-genet-
ic-testing group (p = 
0.03); most common was 
a change in medication/
supplement use (specifi-
cally vitamin E)
1 NR
Sanderson 
[56], 2008
Adult smokers 
(NR; n = 61)
Genetic 
testing
and
High-risk 
genetic 
result
No genetic 
testing
and
Non-risk 
genetic result
Lung cancer 
(GSTM1)
1 week
2 months
Smoking Fewer cigarettes smoked 
(p = 0.009) and greater 
quit rates (p = 0.009) at 
the 1-week follow-up in 
the high-risk genetic 
result group than in the 
no-genetic-testing group; 
NS differences at the 
2-month follow-up 
between the groups for 
cigarettes smoked and 
quit rates
1 No
Rees [57], 
2007
Adult females 
(n = 23)
Genetic 
testing
None Breast cancer 
(BRCA1/2)
Varied – up 
to 18 months
Nutrition (dietary 
changes), physical 
activity, and 
smoking
Few women reported a 
significant impact on 
nutrition, physical 
activity, and/or smoking 
as a result of receiving 
genetic testing results 
and counselling (signifi-
cance level not applica-
ble)
Qualita-
tive
NR
Rief [58], 2007 Adults 
(n = 294)
Genetic 
testing 
and 
consulta-
tion
No genetic 
testing – 
consultation 
only
and
No genetic 
testing 
and no 
consultation
Obesity (NR) 6 months Nutrition 
(restraint eating)
NS changes to restraint 
eating in the genetic 
testing group compared 
to the no-genetic-testing 
groups
1 No
Table 1 (continued)
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cerning, since overall the ratings were “poor” and only 6 
of the 26 studies (23%) received a “good” rating. Thus, it 
is clear that the studies did not provide high-quality in-
terventions to their participants, which helps to explain 
why the majority of studies did not report that genetic 
interventions facilitated lifestyle behaviour change.
Are We Considering Validated Behaviour  
Change Theory?
Consideration of the TPB and/or one or more of the 
theory’s three key components had mode overall ratings 
of “poor.” The deductive content analyses of the theo-
retical underpinnings mentioned in the studies are sum-
marized in online supplementary Table 2. Fifteen studies 
(58%) did not make reference to any specific behaviour 
change theory or model within the text. When a theory 
was included, it was generally only briefly mentioned and 
was not thoroughly incorporated into the study design, or 
expanded upon in the discussion. No study specifically 
referred to the TPB, suggesting that researchers have yet 
to consider this important theory in their study design or 
interpretation of findings. Several studies incidentally 
considered certain aspects of the TPB in the development 
of their scientific methods or within the text, such as the 
consideration of behavioural control by assessing one or 
more social determinants of health, such as income [64]. 
Overall, behaviour change theory is not being thoroughly 
incorporated into genetic testing behaviour change re-
search.
First author 
[Ref.], date
Participants 
(n baseline; 
n follow-up)
Interven-
tion 
group(s)
Comparison 
group(s)
Target diseases/
conditions 
(genes tested)
Follow-up Lifestyle habits 
assessed
Outcomes (p values); 
conclusions
Ranking 
of study 
design1
COI
Carpenter 
[59], 2007
Adult smokers 
(n = 729; 
n = 199)
High-risk 
genetic 
result
Non-risk 
genetic result
Emphysema (AAT) 3 months Smoking Those with high-risk 
genetic results made 
significantly greater quit 
attempts than the non-
risk genetic result group 
(p = 0.004)
3 NR
Ito [60], 2006 Adult smokers 
(n = 697; n = 
369 with data 
for baseline, 
3 and 9 months)
Genetic 
testing
No genetic 
testing
Lung and 
oesophageal cancer 
(L-myc)
3 months
9 months
Smoking NS differences in smok-
ing cessation between 
groups at 3 months 
(significance level NR) 
or 9 months
1 NR
Marteau [61], 
2004
Adult probands 
and their adult 
relatives with 
familial hyper-
cholesterolae-
mia (n = 341; 
n = 275)
Genetic 
testing
No genetic 
testing
Familial 
hypercholes-
terolaemia (NR)
6 months Nutrition (total 
fat and unsaturat-
ed fat), physical 
activity, and 
smoking
NS impact on nutrition, 
physical activity, or 
smoking with genetic 
testing
1 NR
McBride [62], 
2002
Adult smokers 
(n = 557; 
n = 412 at 
6 months, 
n = 356 at 
12 months, 
n = 487 with 
data from all 3 
time points)
Genetic 
testing
No genetic 
testing
Lung cancer 
(GSTM1)
6 months
12 months
Smoking Greater smoking cessa-
tion in the genetic testing 
group than in the no-
genetic-testing group 
(p < 0.006) at 6 months; 
NS smoking cessation 
rates at 12 months
1 NR
Audrain [24], 
1997
Adult smokers 
(n = 550; 
n = 426)
Genetic 
testing
No genetic 
testing
Lung cancer 
(CYP2D6)
12 months Smoking Greater likelihood of quit 
attempts in the genetic 
testing group than in the 
no-genetic-testing group 
(p = 0.02); NS change in 
30-day cessation between 
groups
1 NR
COI, conflict of interest; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; NS, not statistically significant (p > 0.05 unless otherwise stated); NR, not reported; DTC, direct 
to consumer; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid. 1 The rank of the study design is as follows, based on the categories of the NIH Quality Assessment 
Tools [29] in combination with consideration of the hierarchy of evidence [63]: 1 = controlled intervention study; 2 = observational cohort/cross-sectional study; 3 = case-control study; 
4 = pre-post study with no control group. 2 Note: significance levels for this group of participants are reported in Bloss et al. [36].
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Table 2. Summary of quality assessment ratings and impact of genetic testing on lifestyle factor(s) of interest
Ranking 
of study 
design1
First author 
[Ref.], year
Quality assessment rating Key findings: impact of genetic testing on lifestyle 
factor(s) of interest
Source of 
genetic 
information
Specific lifestyle 
factors with significant 
improvement
methods genetic 
info
TPB overall 
quality 
score
nutrition PA smoking nutrition 
and PA
nutrition, 
PA, and 
smoking
1 Roke [43], 2017 Good Fair Fair 7 Δ Other N/A
1 Hietaranta-Luoma 
[9], 2015
Fair Good Poor 6 Pa 
(2 weeks)
Pb 
(6 months)
Pc 
(12 months)
Δ HCP Improved dietary fat 
quality (high-risk genotype 
vs. control at 2 weeks and 
baseline to 6-month 
follow-up in high-risk 
genotype group); 
decreased intake of high-
fat, high-sugar foods (in 
low-risk genotype vs. 
control at 12 months)
1 Marsaux [47], 2015 Fair Fair Poor 5 Δ DTC N/A
1 Meisel [44], 2015 Poor Fair Fair 5 Δ Δ DTC N/A
1 Voils [46], 2015 Fair Good Poor 6 Pd 
(3 months)
Δ 
(6 months)
Δ HCP Reduced calories and fat 
(MUFA and PUFA)
1 Nielsen [11], 2014 Good Fair Poor 6 Δ 
(3 months)
Pa 
(12 months)
DTC Reduced sodium intake
1 Hollands [50], 2012 Good Good Poor 7 Δ Other N/A
1 Hishida [52], 2010 Poor Poor Poor 3 Δ HCP N/A
1 Chao [55], 2008 Fair Poor Poor 4 Δ Δ Pa, e HCP General improvements to 
nutrition and PA; vitamin 
E supplementation was the 
most common change 
reported
1 Sanderson [56], 2008 Poor Fair Fair 5 Pa 
(1 week) 
Δ 
(2 months)
HCP Fewer cigarettes smoked 
and greater smoking 
cessation
1 Rief [58], 2007 Fair Good Poor 6 Δ HCP N/A
1 Ito [60], 2006 Poor Good Fair 6 Δ Other N/A
1 Marteau [61], 2004 Fair Fair Fair 6 Δ Δ Δ HCP N/A
1 McBride [62], 2002 Poor Good Fair 6 Pd 
(6 months)
Δ 
(12 
months)
Other Greater smoking cessation
1 Audrain [24], 1997 Fair Fair Fair 6 Pd (quit 
attempts)
Δ (30-day 
cessation)
HCP Greater likelihood of quit 
attempts
Summary2 (n = 15) Fair Fair Poor 5.6 3/8 0/6 3/7 1/1
2 Egglestone [8], 2013 Poor Poor Poor 3 Pd Pd Δ Pd DTC Greater health behaviour 
scores; the most common 
changes were “healthier 
diet,” “more exercise,” and 
“taking vitamins or 
supplements”; more often 
reported “sufficient fruit 
and vegetable intake”
Horne/Madill/O’Connor/Shelley/GillilandLifestyle Genomics 2018;11:49–6358
DOI: 10.1159/000488086
Ranking 
of study 
design1
First author 
[Ref.], year
Quality assessment rating Key findings: impact of genetic testing on lifestyle 
factor(s) of interest
Source of 
genetic 
information
Specific lifestyle 
factors with significant 
improvement
methods genetic 
info
TPB overall 
quality 
score
nutrition PA smoking nutrition 
and PA
nutrition, 
PA, and 
smoking
2 Kaufman [49], 2012 Fair Poor Poor 4 Pe Pe DTC + 
optional HCP
“Changed their diet” and 
“started exercising more”
Summary2 (n = 2) Fair – 
poor
Poor Poor 3.5 2/2 2/2 0/1 1/1
3 Marsaux [10], 2016 Fair Fair Poor 5 Δ DTC N/A
3 Vernarelli [51], 2010 Good Poor Poor 5 Pe Δ HCP Greater changes in 
supplement use; vitamin E, 
vitamin C, botanicals, 
multivitamins, vitamin B, 
and fish oil/omega were 
the most common changes 
reported
3 O’Neill [54], 2008 Good Poor Poor 5 Δ Δ HCP N/A
3 Carpenter [59], 2007 Fair Fair Poor 5 Pe DTC + 
optional HCP
Greater 24-h quit attempts
Summary2 (n = 4) Good – 
fair
Fair – 
poor
Poor 5.0 1/2 0/3 1/1
4 Boeldt [45], 2015 Fair Poor Fair 5 Δ Δ DTC + 
optional HCP
N/A
4 Bloss [48], 2013 Fair Poor Fair 5 Δ Δ DTC + 
optional HCP
N/A
4 Bloss [36], 2011 Fair Poor Poor 4 Δ Δ DTC + 
optional HCP
N/A
4 Quach [53], 2009 Fair Poor Fair 5 Δ Δ HCP N/A
Summary2 (n = 4) Fair Poor Fair 4.8 0/4 0/4
Qualitative Rees [57], 2007 Good Poor Poor 5 Δ Δ HCP N/A
Summary2 (n = 1) Good Poor Poor 5.0 0/1 0/1
Summary of all studies 
(n = 26)
FAIR POOR POOR 5.2 Nutrition: 6/18 (33%)
PA: 2/16 (13%)
Smoking: 4/12 (33%)
Studies with significant beneficial 
health behaviour change(s):
7/93 (78%) provided actionable 
recommendations
Studies with null findings:
7/14 (50%) provided actionable 
recommendations
“Other” sources of genetic information: Roke et al. [43], 2017, used a researcher; McBride et al. [62], 2002, used “trained counsellors”; Ito et al. [60], 2006, used a “trained interviewer”; 
Hollands et al. [50], 2009, used a “trained research counsellor.” No studies found a detrimental effect of genetic testing on lifestyle change. P, statistically significant beneficial behaviour 
change(s); Δ, no statistically significant behaviour change(s); blank cells, lifestyle factor(s) of interest was/were not assessed; N/A, not applicable; TPB, theory of planned behaviour; PA, 
physical activity; HCP, genetic intervention offered through a healthcare provider; DTC, genetic intervention offered direct to consumer; Other, another method was used to deliver the 
genetic intervention to the participants; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid. 1 The rank of the study design is as follows, based on the National 
Institutes of Health Quality Assessment Tools [29] and the hierarchy of evidence pyramid [63]: 1 = controlled intervention study; 2 = observational cohort/cross-sectional study; 3 = 
case-control study; 4 = pre-post study with no control group. 2 n = x indicates the total number of studies included in the summary; modes are reported for each of the three quality 
assessment ratings; x/x indicates the number of beneficial behaviour change findings/the total number of studies (note: several studies included multiple analyses such as those with 
more than one follow-up time point, and those assessing more than one lifestyle factor of interest); the overall quality score is represented as a mean. 3 Three studies did not provide 
information about whether or not actionable recommendations were provided. a High-risk genotype vs. control group. b Baseline to 6-month follow-up in high-risk genotype group. 
c Non-risk genotype vs. control group. d Genetic testing group vs. control group. e High-risk genotype group vs. non-risk genotype group.
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Does Genetic Testing Impact Changes in Nutrition, 
Physical Activity, and/or Smoking Behaviour?
Overall. Given the heterogeneity of the literature and 
complexity of genetics-based behaviour change research, 
a cause-and-effect relationship between genetic testing 
and health behaviour change cannot be identified. Nota-
bly, it appears that it is unlikely that genetic testing has 
a “fatalistic” or negative impact on health behaviour 
change related to nutrition, physical activity, and smok-
ing, since no study found that genetic testing negatively 
impacted the health behaviours of interest to the present 
review. Interestingly, 78% of the studies with health-pro-
moting lifestyle behaviour change findings provided 
their participants with a genetics-based intervention that 
included actionable health behaviour recommendations. 
Examples of actionable recommendations provided to 
participants for each lifestyle factor included recommen-
dations to reduce sodium intake (nutrition) [11], incor-
porate exercise into one’s daily routine (physical activity) 
[44], and quit smoking (smoking) [24]. Conversely, only 
50% of the studies with null findings provided their par-
ticipants with actionable health behaviour recommenda-
tions. Since an overarching cause-and-effect statement 
about the impact of genetic testing on behaviour change 
cannot be made, a best evidence synthesis is provided 
below.
Nutrition. Of the 18 articles that assessed a nutrition-
related outcome, 6 (33%) showed a positive, health-pro-
moting effect of genetic testing on behaviour change at 
one or more time points (both short term and long term, 
as further outlined in Tables 1 and 2). While this does not 
indicate that the majority of studies positively influenced 
nutrition, multiple studies of good quality have demon-
strated that it is possible to facilitate healthier nutritional 
behaviours through the provision of genetic testing [8, 9, 
11, 46, 49, 51].
Physical Activity. The provision of genetic testing to 
facilitate physical activity behaviour change does not ap-
pear to be as promising as behaviour change related to 
nutrition. Of the 16 studies that analysed physical activi-
ty-related outcomes independently, only 2 (13%) found 
positive influences of genetic testing on physical activity 
[8, 49], with follow-up periods ranging from 2 to 8 months 
in one study [49] and the periods not indicated in the 
other study (follow-up varied for each participant) [8]. 
However, these articles rated poorly in their overall qual-
ity assessment, with “poor” to “fair” quality ratings of 3 
[8] and 4 [49].
Smoking. Similar to nutrition, 4 (33%) of the 12 ge-
netic intervention studies had a positive influence on 
smoking-related behaviours. However, improvements in 
smoking-related behaviours were generally only sus-
tained over a short-term period. The overall quality of 
these studies was “fair.”
Sleep. It is clear that sleep is an understudied area of 
genetic testing and behaviour change research, since our 
comprehensive search did not yield a single study that 
assessed sleep (sleep quality, hours of sleep, etc.) as a be-
haviour change outcome.
Pooled Analyses. Two studies completed pooled analy-
ses of changes in more than one lifestyle factor. Chao et 
al. [65] did not find significant changes in nutrition or 
physical activity on their own, but when pooled together, 
there were significantly greater changes to nutrition and 
physical activity in the high-risk genetic testing group 
than in the non-risk and control groups. Additionally, in 
a pooled analysis of changes to nutrition, physical activ-
ity, or smoking, Egglestone et al. [8] found significant 
changes between the genetic testing group and the con-
trol group. However, their results should be interpreted 
with caution, as this study was awarded the lowest overall 
quality rating of 3 (Table 3).
Results from Controlled Intervention Trials
While it is important to be comprehensive and con-
sider all studies conducted on the topic of interest regard-
less of the research methods chosen, controlled interven-
tions should be further highlighted and reviewed sepa-
rately from other study designs given that this is the 
highest possible level of evidence for the original research 
included in the present review.
In total, 15 controlled intervention trials have been 
conducted over the past two decades. Approximately half 
of these studies (n = 7; 47%) found significant changes in 
nutrition and/or physical activity or in smoking at 1–3 
time points included in the study. Consistent with the 
overall analysis, the controlled interventions found that 
nutrition was the most promising area of behaviour 
change, followed by smoking (short-term only).
The genetic interventions in the controlled interven-
tion trials overall ranked “fair,” demonstrating that in 
comparison to the result of the pooled analysis of all study 
designs, these studies provided their participants with 
higher-quality genetic interventions. This may help ex-
plain why 47% of the controlled intervention studies 
found significant changes in lifestyle habits resulting 
from the genetic intervention, compared to 36% of the 
studies using other study designs. The overall ranking of 
these studies was “fair,” with a mean rating of 5.6 out of 
the highest possible score of 9. Risk of bias overall was 
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“fair” and consideration of the TPB was rated to be “poor,” 
which is consistent with the results of the analysis of all 
study designs combined.
Discussion
Given that decoding the entire human genome was the 
primary focus of genetic research until 2003 [1], it is not 
surprising to find that the majority of studies included in 
the present review were published after this time, with 
only 2 studies published before 2003. Since then, much 
greater focus has been placed on genetic testing behav-
iour change research pertaining to nutrition, physical ac-
tivity, and smoking. However, several studies included in 
the present review (46%) did not include a COI state-
ment. Future research should ensure the inclusion of a 
COI statement given this concerning finding and given 
the increased emphasis in academia on the importance of 
considering COI in genetic testing and other research.
Improving one or more of the four lifestyle behaviours 
of interest to this review has been shown to have a benefi-
cial effect on chronic disease management and general 
health and well-being [20–23]. The present review indi-
cated that improvements to smoking habits were promis-
ing in the short-term. This finding was consistent with 
that of a previously published systematic review of the 
impact of genetic notification on smoking cessation [66].
While nutrition, physical activity, and smoking habits 
have been researched in multiple genetic intervention 
studies, sleep remains an understudied area of genetics 
and behaviour change. This is notable considering the 
substantial impact that sleep has on overall health and 
well-being. Current systematic reviews demonstrate a 
significant impact of sleep on cognition and emotion 
[67], glycaemic control [22], and overweight or obesity 
[23], to name a few. To our knowledge, little is known 
about the ability of sleep to modify gene-associated health 
risks. Thus, future research should seek to first determine 
gene-sleep interactions that may influence health out-
comes using methodologies similar to those of nutrige-
nomics research, as opposed to a genome-wide associa-
tion study approach. Upon determining ways in which 
sleep may mitigate genetics-associated health risks, future 
research should then seek to determine if genetic testing 
helps to motivate healthy sleep-related behaviours.
The considerable heterogeneity in studies (Tables 1, 2) 
can be explained by a number of factors. Notably, the 
variation of statistical analyses between groups (i.e., ge-
netic testing groups vs. control groups or high-risk ge-
netic result groups vs. non-risk genetic result groups) 
would have impacted the findings and subsequent con-
clusions drawn. Consideration of theories in general to 
inform the study design was poor, and consideration of 
the TPB was absent, which further helps to explain the 
heterogeneity of findings, since several possible con-
founding factors were missed. Additionally, only 3 stud-
ies [9, 11, 43] focused on nutrient metabolism. Therefore, 
a future focus is needed on genetic interventions related 
to nutrient metabolism and the subsequent disease risk 
through genetic testing of modifier genes (genetic risks 
that can be mitigated through specific lifestyle changes), 
rather than genetics-based disease risk estimates where 
there may be no known lifestyle modifications that can 
alter the genetic risk. It is possible that nutrition was the 
most promising lifestyle factor for promoting health be-
haviour change given that genetic testing of modifier 
genes typically leads to the provision of actionable recom-
Table 3. Frequencies of genes tested in genetic interventions and 
their reported associated health outcomes
Gene Frequency Health outcomes reported to be  
associated with the gene
AAT 1 Emphysema
ACE 1 Salt sensitivity
apoE 3 Alzheimer disease
Cardiovascular disease
BRCA1 3 Breast cancer
Ovarian cancer
BRCA2 3 Breast cancer
Ovarian cancer
CYP1A2 1 Caffeine metabolism
CYP2D6 1 Lung cancer
FADS1 1 Omega-3 metabolism
FTO 3 Overweight/obesity
GSMT1 3 Lung cancer
Vitamin C utilization
GSTT1 1 Vitamin C utilization
KCNJ11 1 Type 2 diabetes
L-myc 2 Lung cancer
Oesophageal cancer
NOD2 1 Crohn disease
PPARγ 1 Type 2 diabetes
TAS1R2 1 Sweet taste preference
TCF7L2 1 Type 2 diabetes
Of the studies that reported the specific genes tested in the 
genetic intervention, single nucleotide polymorphisms in 16 
unique genes were tested, with apoE, BRCA1/2, FTO, and GSTM1 
having the highest frequencies of use in the genetic intervention.
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mendations (e.g., the recommendation to reduce sodium 
intake [11]).
It is important to note that our risk-of-bias results are 
consistent with the previously published literature [3, 6], 
providing validation for the NIH quality assessment pro-
cess completed in the current review. Effect sizes were not 
included in this review due to heterogeneity of the genet-
ic interventions and study designs of the included articles 
that would have introduced potential flaws in effect size 
calculations and any conclusions drawn from such calcu-
lations. For randomized controlled trials, effect sizes have 
recently been presented elsewhere [3], although these 
should be interpreted with caution due to the significant 
heterogeneity of treatments (genetic interventions), mea-
surements of outcomes, and populations studied. To our 
knowledge, we have developed and utilized the first qual-
ity assessment tool for evaluating and rating genetic 
interventions. Future research should seek to utilize this 
novel tool and significant contribution to the literature to 
assess the quality of genetic interventions in both pri- 
mary research and systematic reviews. Furthermore, the 
components of this tool can be used in future genetic test-
ing behaviour change study design to improve the quality 
of genetic interventions provided to participants (online 
suppl. Table 1). Although the genetic intervention quality 
assessment was based on previously published robust re-
search and critical commentaries [11, 31–38], assessing 
the quality of evidence supporting the genetic tests pro-
vided to participants was beyond the scope of the present 
review. This is an important area of future research and 
is a notable ethical concern of genetic testing.
This review provides the most comprehensive analysis 
of genetic testing behaviour change research completed 
to date. However, some limitations to the present review 
exist. While this review summarized whether the genetic 
information was delivered direct to consumer or through 
a healthcare provider (Table 3), the practice of each pro-
vider is inevitably distinct. Some may incorporate behav-
iour change theory into their practice in order to maxi-
mally promote health behaviour change, while others 
may simply provide an explanation of the genetic results. 
This limitation further highlights the complexity of ge-
netic testing behaviour change research. Additionally, the 
TPB was chosen as the key theory of interest given that it 
is one of the most widely accepted and validated theories 
of behaviour change, with over 4,500 publications refer-
encing this theory and several meta-analyses finding that 
the key components of the TPB can be used to predict 
behavioural intentions with mean multiple correlations 
ranging from 0.59 to 0.67 [15, 68–73]. However, a num-
ber of other theories have been validated and are fre-
quently used in behaviour change research, such as the 
transtheoretical model [74].
By improving upon genetic testing behaviour change 
studies, we anticipate the development of an algorithm 
that can be used to inform effective genetic testing be-
haviour change interventions for individuals who might 
benefit from this more personalized approach to health-
care. Indeed the limitations of genetic testing and the 
possible risk of harm [75] should be considered prior to 
an individual’s decision to undergo genetic testing, espe-
cially in situations where one may learn about their risk 
of developing a disease, where actionable strategies for 
mitigating the risk are currently unknown [75]. Given 
that behaviour change is complex and multifactorial and 
studies have yet to robustly incorporate validated theory 
and high-quality genetic interventions into their meth-
ods, we cannot conclude with a broad statement about 
the impact of genetic testing on behaviour change. How-
ever, it is clear that it is possible to facilitate behaviour 
change through the provision of high-quality genetic 
interventions. Incorporating behaviour change theory 
into future research is an important consideration to en-
hance our knowledge in this field. Specific recommenda-
tions for study design have recently been published else-
where [18]. An interdisciplinary research team with ex-
pertise in genomics as well as behaviour change may be 
the optimal approach given the complexities of this field 
of study. Considerable future research is needed in this 
promising and exciting area of lifestyle behaviour change 
research.
Conclusion
The use of validated theory to inform a robust study 
design [18] and the provision of actionable, high-quality, 
genetics-based information and advice is recommended 
to test a behaviour change hypothesis in genetics research. 
Rather than using the traditional systematic review pro-
cess of assessing solely risk of bias, we have demonstrated 
that factors beyond risk of bias influence research out-
comes related to genetic testing and behaviour change. As 
more robust literature continues to be published, allow-
ing for the determination of key components of genetic 
interventions that best facilitate behaviour change, life-
style genomics behaviour change research has the poten-
tial to make a substantial impact on global health and 
well-being through the facilitation of personalized, 
health-promoting lifestyle behaviour change.
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